JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 14, 2006; DOI: 10.1124/jpet.106.103358


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.103358v1
318/1/373    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alonso-Escolano, D.
Right arrow Articles by Radomski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alonso-Escolano, D.
Right arrow Articles by Radomski, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Breast Cancer


Received for publication March 1, 2006.
Revised April 13, 2006.
Accepted for publication April 13, 2006.

PKC{delta} Mediates Platelet-Induced Breast Cancer Cell Invasion

David Alonso-Escolano 1, Carlos Medina 1, Katarzyna Cieslik 1, Anna Radomski 1, Paul Jurasz 1, Maria Jose Santos-Martinez 1, Tilahum Jiffar 1, Peter Ruvolo 1, Marek Radomski 1*

1 Institute of Molecular Medicine, University of Texas-Houston

* Address correspondence to: E-mail: radomskm{at}tcd.ie

Abstract

Background: Platelets play an important role in carcinogenesis, but the underlying molecular mechanisms remain poorly understood. Aim: to investigate the effects of platelets on in vitro invasion of MCF7 human breast cancer cells. Methods: Human MCF7 cells were used to study their interactions with platelets using aggregometry and cell invasion chambers. Zymography and quantitative PCR were used to study matrix metalloproteinases (MMPs), whereas western blot was used to study PKC{delta} in MCF7 cells. Results: We observed that platelets promoted invasion of MCF7 cells (3 fold-increase, p<0.05, n=3) and that this process correlated with a dramatic increase in MMP-9 (8 fold-increase, p<0.001, n=3), which is known to facilitate cancer cell invasion. Since both, platelets and MCF7 cells have been shown to release MMP-9, we investigated the cellular source that accounted for this increase. The time-course and the use of specific protein synthesis inhibitors demonstrated that most of the increase in MMP-9 levels derived from de novo synthesis of this protease by cancer cells. Furthermore, platelets activated PKC{delta} in MCF7 cells after one hour of incubation (18.45±4.75% increase, p<0.05, n=4-7), which, in turn, led to an upregulation of MMP-9 mRNA (from 60 ± 20 to 1040 ± 100 pg, p<0.001, n=3) and protein levels (18-fold increase, p<0.001, n=3), with the subsequent cell invasion-promoting effects. Conclusion: PKC{delta} plays a crucial role in transducing the invasion-promoting effects of platelets in breast cancer cells and the specific inhibition of PKC{delta} may be a strategy to decrease platelet-mediated cancer cell invasion.


Key words: TCIPA, breast cancer, cancer cell invasion, matrix metalloproteinases, platelets, protein kinase C





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.